Elie A Akl1, Vivian Welch2, Kevin Pottie3, Javier Eslava-Schmalbach4, Andrea Darzi5, Ivan Sola6, Srinivasa Vittal Katikireddi7, Jasvinder Singh8, M Hassan Murad9, Joerg Meerpohl10, Roger Stanev11, Eddy Lang12, Elizabeth Matovinovic13, Beverley Shea14, Thomas Agoritsas15, Paul E Alexander15, Alexandra Snellman16, Romina Brignardello-Petersen17, David Gloss18, Lehana Thabane15, Chunhu Shi19, Airton T Stein20, Ravi Sharaf21, Matthias Briel22, Gordon Guyatt15, Holger Schünemann23, Peter Tugwell24. 1. Clinical Research Institute, American University of Beirut, PO Box 11-0236, Riad El Solh, Beirut, 1107 2020, Lebanon; Department of Medicine, American University of Beirut, PO Box 11-0236, Riad El Solh, Beirut, 1107 2020, Lebanon; AUB GRADE Center, American University of Beirut, PO Box 11-0236, Riad El Solh, Beirut, 1107 2020, Lebanon. Electronic address: ea32@aub.edu.lb. 2. Bruyére Research Institute, Bruyére Continuing Care and University of Ottawa, Bruyère St., Ottawa, Ontario, K1N 5C8, Canada. 3. Centre for Global Health, Institute of Population Health, University of Ottawa, 43 Bruyère St, Ottawa, Ontario, K1N 5C8, Canada. 4. Group of Equity in Health, Faculty of Medicine, Universidad Nacional de Colombia, Edif. Uriel Gutiérrez, Bogotá D.C., Colombia; Technology Development Center, Sociedad Colombiana de Anestesiologia y Reanimacion, Sociedad Colombiana de Anestesiología y ReanimaciónCra, 15 A No 120-74, Piso 4y5, Edif. Concord Center, Santa Fe de Bogotá, Colombia. 5. Clinical Research Institute, American University of Beirut, PO Box 11-0236, Riad El Solh, Beirut, 1107 2020, Lebanon; AUB GRADE Center, American University of Beirut, PO Box 11-0236, Riad El Solh, Beirut, 1107 2020, Lebanon. 6. Clinical Epidemiology and Public Health Department, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), C/Sant Antoni Maria Claret, 167, Pavelló 18, planta 0, 08025 Barcelona, Spain. 7. Public Health MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, 200, Renfield Street, Glasgow G2 3QB, Scotland. 8. Department of Medicine, School of Medicine, Birmingham VA Medical Center, 700 19th St S, Birmingham, AL 35233, USA; Division of Epidemiology, School of Public Health, University of Alabama at Birmingham (UAB), 1720 2nd Ave S, Birmingham, AL 35294, USA; Department of Orthopedic Surgery, Mayo Clinic College of Medicine, 5777 E. Mayo Blvd., Phoenix, AZ 85054, USA. 9. Mayo Clinic Evidence-based Practice Center, Preventive Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA. 10. Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité-U1153, Inserm/Université Paris Descartes, 1 place du Parvis Notre-Dame, 75004 Paris, France; Cochrane France, Hôpital Hôtel-Dieu, 1 place du Parvis Notre Dame, 75181 Paris, Cedex 04, France; Cochrane Germany, Medical Center-University of Freiburg, Breisacher Strasse 153, 79110 Freiburg, Germany. 11. Institute of Technology, University of Washington, Tacoma, Washington, USA. 12. Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW Calgary, Alberta, T2N 4N1, Canada. 13. Faculty of Medicine, Chiang Mai University, Su Thep, Mueang Chiang Mai District, Chiang Mai 50200, Thailand. 14. Ottawa Hospital Research Institute, University of Ottawa, 75 Laurier Ave E, Ottawa, Ontario, K1N 6N5, Canada. 15. Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, Hamilton, 1280 Main St., W.Hamilton, Ontario, L8S 4K1, Canada; Department of Medicine, Faculty of Health Sciences, Hamilton, 1280 Main St., W. Hamilton, Ontario, L8S 4K1, Canada. 16. Socialstyrelsen, Rålambsvägen 3, Stockholm, 112 59, Sweden. 17. Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, Hamilton, 1280 Main St., W.Hamilton, Ontario, L8S 4K1, Canada; Department of Medicine, Faculty of Health Sciences, Hamilton, 1280 Main St., W. Hamilton, Ontario, L8S 4K1, Canada; Evidence Based Dentistry Unit, Faculty of Dentistry, University of Chile, Av. Libertador Bernardo O'Higgins, Santiago 1058, Chile. 18. Department of Neurology, Charleston Area Medical Center, 1201 Washington Street East, Suite 100, Charleston, WV 25301, USA. 19. Division of Nursing, Midwifery & Social Work, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Rd, Manchester M13 9PL, UK. 20. Public Health Ufcspa, Ulbra and Conceicao Hospital, Av. Farroupilha, 8001, Bairro São José, Canoas (RS), Brasil. 21. Long Island Jewish Medical Center North Shore University Hospital, 270-05 76th Ave, Queens, NY 11040, USA. 22. Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Spitalstrasse 21, 4056 Basel, Switzerland. 23. Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, Hamilton, 1280 Main St., W.Hamilton, Ontario, L8S 4K1, Canada; Department of Medicine, Faculty of Health Sciences, Hamilton, 1280 Main St., W. Hamilton, Ontario, L8S 4K1, Canada; McMaster GRADE Center, McMaster University, 1280 Main St W, Hamilton, Ontario, L8S 4L8, Canada; Department of Medicine, McMaster University, 1280 Main St W, Hamilton, Ontario, L8S 4L8, Canada. 24. The Centre for Global Health, Institute of Population Health, University of Ottawa, 75 Laurier Ave E, Ottawa, Ontario, K1N 6N5, Canada.
Abstract
OBJECTIVE: To provide guidance for guideline developers on how to consider health equity at key stages of the guideline development process. STUDY DESIGN AND SETTING: Literature review followed by group discussions and consensus building. RESULTS: The key stages at which guideline developers could consider equity include setting priorities, guideline group membership, identifying the target audience(s), generating the guideline questions, considering the importance of outcomes and interventions, deciding what evidence to include and searching for evidence, summarizing the evidence and considering additional information, wording of recommendations, and evaluation and use. We provide examples of how guidelines have actually considered equity at each of these stages. CONCLUSION: Guideline projects should consider the aforementioned suggestions for recommendations that are equity sensitive.
OBJECTIVE: To provide guidance for guideline developers on how to consider health equity at key stages of the guideline development process. STUDY DESIGN AND SETTING: Literature review followed by group discussions and consensus building. RESULTS: The key stages at which guideline developers could consider equity include setting priorities, guideline group membership, identifying the target audience(s), generating the guideline questions, considering the importance of outcomes and interventions, deciding what evidence to include and searching for evidence, summarizing the evidence and considering additional information, wording of recommendations, and evaluation and use. We provide examples of how guidelines have actually considered equity at each of these stages. CONCLUSION: Guideline projects should consider the aforementioned suggestions for recommendations that are equity sensitive.
Authors: Peter Tugwell; Mark Petticrew; Elizabeth Kristjansson; Vivian Welch; Erin Ueffing; Elizabeth Waters; Josiane Bonnefoy; Antony Morgan; Emma Doohan; Michael P Kelly Journal: BMJ Date: 2010-09-13
Authors: Gordon H Guyatt; Andrew D Oxman; Regina Kunz; David Atkins; Jan Brozek; Gunn Vist; Philip Alderson; Paul Glasziou; Yngve Falck-Ytter; Holger J Schünemann Journal: J Clin Epidemiol Date: 2010-12-30 Impact factor: 6.437
Authors: Antonio Miguel Dans; Leonila Dans; Andrew David Oxman; Vivian Robinson; Joselito Acuin; Peter Tugwell; Rodolfo Dennis; Deying Kang Journal: J Clin Epidemiol Date: 2007-01-18 Impact factor: 6.437
Authors: Monica Malta; Monica M F Magnanini; Maeve B Mello; Ana Roberta P Pascom; Yohana Linhares; Francisco I Bastos Journal: BMC Public Health Date: 2010-06-07 Impact factor: 3.295
Authors: Kevin Pottie; Vivian Welch; Rachael Morton; Elie A Akl; Javier H Eslava-Schmalbach; Vittal Katikireddi; Jasvinder Singh; Lorenzo Moja; Eddy Lang; Nicola Magrini; Lehana Thabane; Roger Stanev; Elizabeth Matovinovic; Alexandra Snellman; Matthias Briel; Beverly Shea; Peter Tugwell; Holger Schunemann; Gordon Guyatt; Pablo Alonso-Coello Journal: J Clin Epidemiol Date: 2017-08-10 Impact factor: 6.437
Authors: Sara Dahlen; Dean Connolly; Isra Arif; Muhammad Hyder Junejo; Susan Bewley; Catherine Meads Journal: BMJ Open Date: 2021-04-29 Impact factor: 2.692
Authors: Javier Eslava-Schmalbach; Paola Mosquera; Juan Pablo Alzate; Kevin Pottie; Vivian Welch; Elie A Akl; Janet Jull; Eddy Lang; Srinivasa Vittal Katikireddi; Rachel Morton; Lehana Thabane; Bev Shea; Airton T Stein; Jasvinder Singh; Ivan D Florez; Gordon Guyatt; Holger Schünemann; Peter Tugwell Journal: Health Policy Plan Date: 2017-12-01 Impact factor: 3.344
Authors: Jennifer Petkovic; Alison Riddle; Elie A Akl; Joanne Khabsa; Lyubov Lytvyn; Pearl Atwere; Pauline Campbell; Kalipso Chalkidou; Stephanie M Chang; Sally Crowe; Leonila Dans; Fadi El Jardali; Davina Ghersi; Ian D Graham; Sean Grant; Regina Greer-Smith; Jeanne-Marie Guise; Glen Hazlewood; Janet Jull; S Vittal Katikireddi; Etienne V Langlois; Anne Lyddiatt; Lara Maxwell; Richard Morley; Reem A Mustafa; Francesco Nonino; Jordi Pardo Pardo; Alex Pollock; Kevin Pottie; John Riva; Holger Schünemann; Rosiane Simeon; Maureen Smith; Airton T Stein; Anneliese Synnot; Janice Tufte; Howard White; Vivian Welch; Thomas W Concannon; Peter Tugwell Journal: Syst Rev Date: 2020-02-01